They concluded that RCC could activate EC through VEGF-dependent and -independent pathways, and combined inhibition of VEGF/PDGF/FGF receptors could inhibit mitogenic signaling in Ecs but not in fibroblasts. This evidence concerns the gene VEGFA and renal cell carcinoma.